{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:16:31Z","timestamp":1787508991467,"version":"build-2736575974"},"reference-count":31,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,10,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVES:<\/jats:title>\n                    <jats:p>Vaso-occlusive episodes (VOEs) account for the majority of emergency department (ED) visits for children with sickle cell disease (SCD). We hypothesized that addressing key barriers to VOE care would improve receipt of analgesics and outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>A quality improvement (QI) initiative was conducted from September 2010 to April 2014 to streamline VOE care in an urban pediatric ED. Four interventions were used: a standardized time-specific VOE protocol; intranasal fentanyl as the first parenteral pain medication; an SCD pain medication calculator; and provider and patient\/family education. Data were collected for 3 outcome measures (mean time from triage to first parenteral opioid and admission\/discharge decision, and proportion discharged from the ED); 1 process measure (mean time from triage to initiation of patient-controlled analgesia); and 4 balancing measures (mean time from triage to second intravenous opioid dose, 24-hour ED readmission, respiratory depression, and length of stay).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>There were 289 ED visits in the study period. Improvements were seen in mean time to: first dose of parenteral opioid (56 to 23 minutes); second opiate intravenous dose (106 to 83 minutes); admission and discharge decisions (163 to 109 minutes and 271 to 178 minutes, respectively); and initiation of patient-controlled analgesia (216 to 141 minutes). The proportion discharged from the ED increased from 32% to 48% (\u03c72 = 6.5402, P = .01). No increase in 24-hour readmission, respiratory depression, or inpatient length of stay was observed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Using VOE-specific interventions, we significantly improved VOE care for children. Studies are needed to determine if these results can be replicated.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1542\/peds.2014-3470","type":"journal-article","created":{"date-parts":[[2015,9,21]],"date-time":"2015-09-21T20:20:37Z","timestamp":1442866837000},"page":"e1016-e1025","source":"Crossref","is-referenced-by-count":70,"title":["Improving the Management of Vaso-Occlusive Episodes in the Pediatric Emergency Department"],"prefix":"10.1542","volume":"136","author":[{"given":"Patricia L.","family":"Kavanagh","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Boston University School of Medicine\/Boston Medical Center, Boston, Massachusetts; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippa G.","family":"Sprinz","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Boston University School of Medicine\/Boston Medical Center, Boston, Massachusetts; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahlia L.","family":"Wolfgang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Boston University School of Medicine\/Boston Medical Center, Boston, Massachusetts; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Killius","sequence":"additional","affiliation":[{"name":"Departments of Pharmacy,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Champigny","sequence":"additional","affiliation":[{"name":"Social Work, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Sobota","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Boston University School of Medicine\/Boston Medical Center, Boston, Massachusetts; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dorfman","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Boston University School of Medicine\/Boston Medical Center, Boston, Massachusetts; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karan","family":"Barry","sequence":"additional","affiliation":[{"name":"Nursing, Boston Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee","family":"Miner","sequence":"additional","affiliation":[{"name":"Nursing, Boston Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Moses","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Boston University School of Medicine\/Boston Medical Center, Boston, Massachusetts; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2015,10,1]]},"reference":[{"key":"2021120908454512400_B1","doi-asserted-by":"crossref","first-page":"S512","DOI":"10.1016\/j.amepre.2009.12.022","article-title":"Population estimates of sickle cell disease in the U.S.","volume":"38","author":"Hassell","year":"2010","journal-title":"Am J Prev Med"},{"issue":"1","key":"2021120908454512400_B2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/ajh.21570","article-title":"The number of people with sickle-cell disease in the United States: national and state estimates.","volume":"85","author":"Brousseau","year":"2010","journal-title":"Am J Hematol"},{"issue":"2","key":"2021120908454512400_B3","doi-asserted-by":"crossref","first-page":"94","DOI":"10.7326\/0003-4819-148-2-200801150-00004","article-title":"Daily assessment of pain in adults with sickle cell disease.","volume":"148","author":"Smith","year":"2008","journal-title":"Ann Intern Med"},{"key":"2021120908454512400_B4","doi-asserted-by":"crossref","first-page":"S536","DOI":"10.1016\/j.amepre.2010.01.001","article-title":"Emergency department visits made by patients with sickle cell disease: a descriptive study, 1999-2007.","volume":"38","author":"Yusuf","year":"2010","journal-title":"Am J Prev Med"},{"issue":"4","key":"2021120908454512400_B5","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/pbc.22069","article-title":"Health care utilization and expenditures for privately and publicly insured children with sickle cell disease in the United States.","volume":"53","author":"Mvundura","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"2021120908454512400_B6","unstructured":"National Heart Lung and Blood Institute. Evidence-based management of sickle cell disease: expert panel report. National Institutes of Health. Available at: www.nhlbi.nih.gov\/health-pro\/guidelines\/sickle-cell-disease-guidelines\/sickle-cell-disease-report.pdf. Accessed September 10, 2014"},{"key":"2021120908454512400_B7","volume-title":"Guideline for the Management of Acute and Chronic Pain in Sickle Cell Disease","author":"Benjamin","year":"1999"},{"issue":"3","key":"2021120908454512400_B8","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1542\/peds.2010-1791","article-title":"Quality-of-care indicators for children with sickle cell disease.","volume":"128","author":"Wang","year":"2011","journal-title":"Pediatrics"},{"issue":"10","key":"2021120908454512400_B9","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/PEC.0b013e3182302871","article-title":"Emergency department crowding and analgesic delay in pediatric sickle cell pain crises.","volume":"27","author":"Shenoi","year":"2011","journal-title":"Pediatr Emerg Care"},{"issue":"3","key":"2021120908454512400_B10","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/pbc.21847","article-title":"Clinical practice guideline improves the treatment of sickle cell disease vasoocclusive pain.","volume":"52","author":"Morrissey","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"2021120908454512400_B11","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jemermed.2009.06.003","article-title":"Do children with sickle cell disease receive disparate care for pain in the emergency department?","volume":"39","author":"Zempsky","year":"2010","journal-title":"J Emerg Med"},{"issue":"7\u20138","key":"2021120908454512400_B12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0027-9684(15)30174-7","article-title":"Setting the agenda for quality improvement in pediatric sickle cell disease.","volume":"104","author":"Kenyon","year":"2012","journal-title":"J Natl Med Assoc"},{"key":"2021120908454512400_B13","volume-title":"Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education and Research","author":"Institute of Medicine","year":"2011"},{"issue":"22","key":"2021120908454512400_B14","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1001\/jama.2009.1811","article-title":"Treatment of sickle cell pain: fostering trust and justice.","volume":"302","author":"Zempsky","year":"2009","journal-title":"JAMA"},{"issue":"2","key":"2021120908454512400_B15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0304-3959(81)90199-8","article-title":"Measurement of pain: patient preference does not confound pain measurement.","volume":"10","author":"Kremer","year":"1981","journal-title":"Pain"},{"key":"2021120908454512400_B16","volume-title":"The Improvement Guide: A Practical Approach to Enhancing Organizational Performance","author":"Langley","year":"2009","edition":"2nd ed."},{"issue":"3","key":"2021120908454512400_B17","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.annemergmed.2006.06.016","article-title":"A randomized controlled trial comparing intranasal fentanyl to intravenous morphine for managing acute pain in children in the emergency department.","volume":"49","author":"Borland","year":"2007","journal-title":"Ann Emerg Med"},{"issue":"3","key":"2021120908454512400_B18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1442-2026.2002.00344.x","article-title":"Intranasal fentanyl reduces acute pain in children in the emergency department: a safety and efficacy study.","volume":"14","author":"Borland","year":"2002","journal-title":"Emerg Med (Fremantle)"},{"issue":"4","key":"2021120908454512400_B19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1399-6576.2011.02613.x","article-title":"Intranasal fentanyl in the treatment of acute pain\u2014a systematic review.","volume":"56","author":"Hansen","year":"2012","journal-title":"Acta Anaesthesiol Scand"},{"issue":"7","key":"2021120908454512400_B20","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jpain.2006.05.004","article-title":"Sickle cell disease related pain: crisis and conflict.","volume":"7","author":"Todd","year":"2006","journal-title":"J Pain"},{"issue":"1","key":"2021120908454512400_B21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/17423953060020011101","article-title":"Pain management in sickle cell disease.","volume":"2","author":"Booker","year":"2006","journal-title":"Chronic Illn"},{"issue":"6","key":"2021120908454512400_B22","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1136\/qhc.12.6.458","article-title":"Statistical process control as a tool for research and healthcare improvement.","volume":"12","author":"Benneyan","year":"2003","journal-title":"Qual Saf Health Care"},{"issue":"4","key":"2021120908454512400_B23","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/qshc.2004.011650","article-title":"Using statistical process control to improve the quality of health care.","volume":"13","author":"Mohammed","year":"2004","journal-title":"Qual Saf Health Care"},{"issue":"3","key":"2021120908454512400_B24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jemermed.2006.07.022","article-title":"Impact of an emergency department pain management protocol on the pattern of visits by patients with sickle cell disease.","volume":"32","author":"Givens","year":"2007","journal-title":"J Emerg Med"},{"issue":"1","key":"2021120908454512400_B25","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/01.pec.0000106235.72265.29","article-title":"Patient-controlled analgesia for sickle cell pain crisis in a pediatric emergency department.","volume":"20","author":"Melzer-Lange","year":"2004","journal-title":"Pediatr Emerg Care"},{"issue":"1","key":"2021120908454512400_B26","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1745-6215-13-74","article-title":"Intranasal fentanyl versus intravenous morphine in the emergency department treatment of severe painful sickle cell crises in children: study protocol for a randomised controlled trial.","volume":"13","author":"Barrett","year":"2012","journal-title":"Trials"},{"issue":"2","key":"2021120908454512400_B27","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1553-2712.2009.00636.x","article-title":"The implementation of intranasal fentanyl for children in a mixed adult and pediatric emergency department reduces time to analgesic administration.","volume":"17","author":"Holdgate","year":"2010","journal-title":"Acad Emerg Med"},{"issue":"2","key":"2021120908454512400_B28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/bjh.12879","article-title":"Management of the acute painful crisis in sickle cell disease- a re-evaluation of the use of opioids in adult patients.","volume":"166","author":"Telfer","year":"2014","journal-title":"Br J Haematol"},{"key":"2021120908454512400_B29"},{"issue":"5","key":"2021120908454512400_B30","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1542\/peds.2005-2046","article-title":"Pain assessment for pediatric patients in the emergency department.","volume":"117","author":"Drendel","year":"2006","journal-title":"Pediatrics"},{"issue":"9","key":"2021120908454512400_B31","first-page":"509","article-title":"Improving reassessment and documentation of pain management.","volume":"34","author":"Gordon","year":"2008","journal-title":"Jt Comm J Qual Patient Saf"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/136\/4\/e1016\/1060660\/peds_2014-3470.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/136\/4\/e1016\/1060660\/peds_2014-3470.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T04:00:29Z","timestamp":1718078429000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/136\/4\/e1016\/73890\/Improving-the-Management-of-Vaso-Occlusive"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,1]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,10,1]]},"published-print":{"date-parts":[[2015,10,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2014-3470","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,1]]}}}